1. Home
  2. HUMA vs FPH Comparison

HUMA vs FPH Comparison

Compare HUMA & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • FPH
  • Stock Information
  • Founded
  • HUMA 2004
  • FPH 2009
  • Country
  • HUMA United States
  • FPH United States
  • Employees
  • HUMA N/A
  • FPH N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • FPH Real Estate
  • Sector
  • HUMA Health Care
  • FPH Finance
  • Exchange
  • HUMA Nasdaq
  • FPH Nasdaq
  • Market Cap
  • HUMA 367.6M
  • FPH 340.3M
  • IPO Year
  • HUMA N/A
  • FPH 2017
  • Fundamental
  • Price
  • HUMA $2.34
  • FPH $6.04
  • Analyst Decision
  • HUMA Strong Buy
  • FPH
  • Analyst Count
  • HUMA 7
  • FPH 0
  • Target Price
  • HUMA $13.00
  • FPH N/A
  • AVG Volume (30 Days)
  • HUMA 3.4M
  • FPH 142.2K
  • Earning Date
  • HUMA 08-12-2025
  • FPH 07-21-2025
  • Dividend Yield
  • HUMA N/A
  • FPH N/A
  • EPS Growth
  • HUMA N/A
  • FPH 69.50
  • EPS
  • HUMA N/A
  • FPH 1.24
  • Revenue
  • HUMA $517,000.00
  • FPH $241,148,000.00
  • Revenue This Year
  • HUMA N/A
  • FPH N/A
  • Revenue Next Year
  • HUMA $896.45
  • FPH N/A
  • P/E Ratio
  • HUMA N/A
  • FPH $4.86
  • Revenue Growth
  • HUMA N/A
  • FPH 11.66
  • 52 Week Low
  • HUMA $1.15
  • FPH $2.88
  • 52 Week High
  • HUMA $9.79
  • FPH $6.71
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 50.49
  • FPH 59.05
  • Support Level
  • HUMA $2.13
  • FPH $5.66
  • Resistance Level
  • HUMA $2.80
  • FPH $5.93
  • Average True Range (ATR)
  • HUMA 0.18
  • FPH 0.22
  • MACD
  • HUMA 0.01
  • FPH 0.02
  • Stochastic Oscillator
  • HUMA 35.69
  • FPH 71.83

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: